Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory Target
Clinical trial NCT03850301 · RECRUITING
Trial details
- NCT number
- NCT03850301
- Sponsor
- Imperial College London
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2025-01-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.